In the past twenty years, preimplantation genetic diagnosis, also known as PGD has been made use of, to diagnose chromosomal problems or defects in patients with low prognosis. PGD is now being utilized to diagnose a wide variety of symptoms, owing to developments in healthcare sector.
The need for PGD in patients experiencing IVF is constantly expanding. This need is with the hope that it would enhance the prospects of live births and decrease the chances of hereditary abnormalities and other disabilities in the embryo. The preimplantation genetic diagnosis market has bright prospects in the coming years.
This market is fragmented into six kinds of tests and four geographical regions. The preimplantation genetic diagnosis market regions include Asia Pacific, North America, the rest of the world and Europe.